A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/24 (2006.01) A61K 9/00 (2006.01) A61K 31/40 (2006.01) A61K 31/55 (2006.01) A61K 31/70 (2006.01) A61K 31/68 (1995.01)
Patent
CA 2092722
2092722 9204905 PCTABS00011 The invention relates to a method for treating or preventing ocular swelling and corneal-conjunctival inflammation. This is accomplished by administering to the eye of a subject, either before or after exposure to an ocular swelling stimulus, an amount of a heme oxygenase inducing agent sufficient to increase levels of heme oxygenase in the eye and thereby to reduce or to regulate the amount of 19 and 20 hydroxyeicosatetraenoic and 12(R)DiHETE acids present. Particularly preferred agents include stannous compounds, such as SnCl2, other metals, heme derivatives and Vitamin B12. These compounds may be administered in various forms.
Abraham Nader G.
Dunn Michael W.
Levere Richard D.
Schwartzman Michal L.
Abraham Nader G.
Dunn Michael W.
Levere Richard D.
Schwartzman Michal L.
Swabey Ogilvy Renault
LandOfFree
Method for treating eye disorders by reducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating eye disorders by reducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating eye disorders by reducing... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1781795